The commitment of GENESIS Pharma to incorporate quality and excellence into its culture and operations is sealed with another important European distinction.
Following the European Quality Leader 2012 award granted to the founder and CEO of GENESIS Pharma, Mr. Constantinos Evripides , the company received the certification ‘EFQM Recognized for Excellence 4 Star’, as well as the silver award for Business Excellence by the Hellenic Management Association which grants the National Business Excellence Certifications. In 2009, GENESIS Pharma had achieved the EFQM Committed to Excellence recognition.

These models of excellence, along with a range of other international quality management and business excellence standards are incorporated in the company’s sustainable growth strategy. The emphasis on innovation and modern management, its commitment to integrity and transparency towards health care professionals, the long-term relationships and trust that the company builds with all its partners, the ongoing efforts to develop and engage its people and its performance in corporate responsibility issues are the major elements of its culture, which meet the high standards of the EFQM model At the award ceremony, held on Monday, November 18, Mr. Constantinos Evripides, CEO of GENESIS Pharma, stated: “In a time when we need a new sustainable strategy for the Greek economy, entrepreneurship and growth, it is crucial to realize that every business, regardless of size, must be driven by quality and operational excellence. Commitment to quality is a prerequisite in order for a company to gain a competitive advantage, earn market trust and ensure growth even in times of financial crisis.  In GENESIS Pharma we make a daily effort to achieve excellence, from the first day of our foundation. For us, this is a never ending journey. Our next goal is to achieve the EFQM 5 Stars certification.